ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value (IRWD)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: IRONWOOD PHARMACEUTICALS INC Class A common stock, $0.001 par value
Symbol: IRWD
Shares outstanding: 162,690,355 shares
Disclosed Ownership: 16,025,000 shares
Ownership: 9.8%
Form type: SCHEDULE 13G/A
Filing time: 17 Feb 2026, 21:45:58 UTC
Date of event: 31 Dec 2025
Previous filing: 15 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.8%	16,025,000	0	16,025,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.8%	16,025,000	0	16,025,000	/s/ Steven Boyd	Steven Boyd